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Knowledge of human T cells derives chiefly from
studiesof peripheral blood,whereas their distribution
and function in tissues remains largely unknown.
Here, we present a unique analysis of human T cells
in lymphoid and mucosal tissues obtained from
individual organ donors, revealing tissue-intrinsic
compartmentalization of naive, effector, andmemory
subsets conserved between diverse individuals.
Effector memory CD4+ T cells producing IL-2 predo-
minated in mucosal tissues and accumulated as
central memory subsets in lymphoid tissue, whereas
CD8+ T cells were maintained as naive subsets
in lymphoid tissues and IFN-g-producing effector
memory CD8+ T cells inmucosal sites. The T cell acti-
vation marker CD69 was constitutively expressed by
memoryTcells in all tissues,distinguishing them from
circulating subsets, with mucosal memory T cells ex-
hibiting additional distinct phenotypic and functional
properties. Our results provide an assessment of
human T cell compartmentalization as a newbaseline
for understanding human adaptive immunity.
INTRODUCTION
Immunological memory is essential for maintaining immunity to
ubiquitous pathogens and for achieving protection from
vaccines. The importance of T cell memory has been demon-
strated in mouse models of infection, where multiple memory
subsets and their diverse distribution in lymphoid, mucosal,
and other nonlymphoid sites are integral to their protective
capacity and long-term maintenance (Bevan, 2011; Masopust
and Picker, 2012; Sheridan and Lefranc¸ois, 2011; Teijaro et al.,
2011). However, mouse models cannot recapitulate the human
memory immune response and the effects of decades-long
exposure to multiple pathogens. In humans, studies on T cellactivation and memory have been largely limited to T cells iso-
lated from peripheral blood, and very little is known regarding
human T cell activation and differentiation in lymphoid and
mucosal tissue sites. Moreover, there are no strategies to target
memory T cells for promoting long-term immunity in humans,
despite worldwide efforts to develop effective vaccines against
endemic pathogens such as HIV and malaria, chronic viruses
such as HSV and hepatitis, and emerging pandemic strains of
influenza. In order to break new ground in the study of human
immunology and develop effective vaccines and therapies that
specifically target immune responses at the sites where they
are needed, it is essential to move beyond conventional studies
of human peripheral blood and study immune responses in the
tissue sites.
Activation of T lymphocytes occurs in lymphoid tissue and
generates functionally diverse subsets of effector T cells with
the capacity to migrate to multiple tissue sites (Campbell et al.,
2003). Although most activated effector cells die after a brief life-
span, a subset of primed T cells develops into long-livedmemory
T cells that persist as heterogeneous populations in lymphoid
and mucosal sites. Studies in mice have revealed an important
role for tissue-resident memory CD4+ andCD8+ T cells in protec-
tive immunity to site-specific pathogens in the lung and skin
(Gebhardt et al., 2009; Liu et al., 2010; Teijaro et al., 2011) and
that mucosal sites such as lung and intestine contain tissue-
retained memory populations that do not recirculate (Jiang
et al., 2012; Klonowski et al., 2004; Teijaro et al., 2011). These
studies suggest that the protective efficacy of T cell responses
cannot be measured or approximated from studying peripheral
blood. In humans, studies on immune cells in tissue sites are
limited to using individual tissues surgically excised because of
disease. It is not known how circulating T cells are related to
those in lymphoid and mucosal tissue sites within an individual
and howmemory T cell responses are organized andmaintained
throughout the body.
Through the collaboration of the New York Organ Donor
Network (NYODN), the organ procurement organization (OPO)
for the greater New York metropolitan area, we have obtained
access to multiple lymphoid and mucosal tissues from individual
organ donors with a healthy immune system. We present hereImmunity 38, 187–197, January 24, 2013 ª2013 Elsevier Inc. 187
Table 1. Profile of Organ Donors from whom Tissues Were
Obtained for This Study
Donor Code Age Gender Cause of Death
#1 17 M cerebrovascular stroke
#2 15 F head trauma
#3 55 F cerebrovascular stroke
#4 32 M anoxia
#7 31 M head trauma (MVA)
#8 17 M anoxia/suicide
#9 60 F cerebrovascular stroke
#10 39 F cerebrovascular stroke
#11 46 M anoxia/suicide
#12 39 M head trauma (homicide)
#13 48 M cerebrovascular stroke
#16 19 M anoxia/drugs
#18 51 M anoxia/cardiovascular
#26 33 F anoxia/drugs
#27 52 M cerebrovascular stroke
#29 23 F anoxia/suicide
#33 55 F cerebrovascular stroke
#39 32 M anoxia/drugs
#40 30 M cardiac arrest
#41 22 M head trauma (MVA)
#42 54 F cerebrovascular stroke
#43 60 F anoxia/brain edema
#44 50 M cerebrovascular stroke
#45 37 M head trauma (fall)
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Human T Cells in Lymphoid and Mucosal Tissuesa multidimensional analysis of T cells throughout the human
body from 24 different donors aged 15–60 years, revealing
distinct compartmentalization of naive, effector, and memory
CD4+ and CD8+ T cell subsets intrinsic to the tissue site that is
remarkably consistent in diverse individuals. Memory CD4+
T cells represent the majority subset in mucosal tissues and
accumulate in lymphoid tissue throughout life. CD8+ T cell
subsets, by contrast, are maintained as naive cells in lymphoid
compartments over decades, with memory CD8+ T cells mainly
in mucosal sites and terminal effector T cells confined to circu-
lation. Importantly, memory T cells in all tissues specifically
upregulate CD69 expression, a marker of T cell receptor
(TCR)-mediated signaling, which distinguishes tissue-resident
from circulating populations. Functionally, the majority of
tissue-resident T cells were quiescent or IL-2-producingmemory
CD4+ T cells, followed by IFN-g-producingmemory CD8+ T cells,
with IL-17 production confined to memory CD4+ T cells in
mucosal compartments. Our results provide a three-dimensional
analysis of human T cell immunity from which to interpret and
study disease- and pathogen-specific immune responses and
to design new strategies for improving human health through
vaccination and immunomodulation.
RESULTS
Tissue-Specific Compartmentalization of Human
Lymphocytes
In collaboration with the New York Organ Donor Network
(NYODN), we set up a research protocol to obtain multiple
lymphoid and mucosal tissues from individual organ donors at
the time of acquisition for life-saving transplantation. The 24
donors in this study comprise a broad sampling of the population
between the ages of 15 and 60 years (median age 38), all of
whom died suddenly of traumatic causes, such as cerebrovas-
cular stroke (33%), head trauma resulting from motor vehicle
accident or homicide (33%), or anoxia due to suicide, drug-
related deaths, or other causes (33%) (Table 1). All donors
were HIV negative and free of cancer and other chronic or
immunological diseases (data not shown). From each donor,
we obtained blood and eight different healthy tissues including
multiple lymphoid tissues (spleen, inguinal, mesenteric, and
bronchial/lung-draining lymph nodes [LNs]) and mucosal tissues
including the lung, small intestine regions (jejunum, ileum), and
colon (Figure 1).
We isolated mononuclear lymphocytes from all nine tissue
sites (see Experimental Procedures) and obtained high lympho-
cyte yield and excellent sample integrity shown by represen-
tative flow cytometry analysis of CD3 and CD20 expression
indicating frequency of T and B cells, respectively, in each site
(Figure 1A). Within an individual, lymphocyte subset composition
as assessed by the T cell:B cell ratio differed in blood, lymphoid,
andmucosal compartments, whereas spleen contained a similar
frequency of T and B cells and the frequency of T cells outnum-
bered B cells in all other sites: by 2- to 4-fold in blood and LNs, 5-
to 8-fold in ileum and colon, and >15- to 20-fold in the lung and
jejunum (Figures 1A and 1B, top). These tissue-specific lympho-
cyte distribution patterns were remarkably similar between indi-
viduals despite differences in age, cause of death, and lifestyle,
as shown in the compiled ratio plots with limited variance among188 Immunity 38, 187–197, January 24, 2013 ª2013 Elsevier Inc.17 donors (Figure 1B and see Table S1 available online for indi-
vidual data for each donor). In addition, the T cell compartment is
consistently dominated by CD4+ T cells throughout the body,
except for intestines where comparable proportions of CD8+
and CD4+ T cells were found (Figure 1B, bottom). Our results
indicate that lymphocytic composition in humans is intrinsic to
the tissue site regardless of background or antigenic exposure
and that tissues from organ donors can provide a unique snap-
shot into steady-state adaptive immunity in humans that is highly
conserved between individuals.
Memory T Cells Predominate throughout the Body
and Accumulate with Age
Expression of the CD45RO isoform is a well-known marker used
to phenotypically identify memory CD4+ and CD8+ T cells (Dut-
ton et al., 1998; Merkenschlager and Beverley, 1989), and
conversely, CD45RA isoforms are expressed by naive and termi-
nally differentiated effector cells (Sallusto et al., 1999, 2004). We
analyzed the proportion of CD45RO+ memory CD4+ and CD8+
T cells in each tissue compared to CD45RA subsets from
multiple donors. As shown in a representative CD45RO versus
CD45RA staining profile of nine tissue sites from a donor near
the median age (donor 39, age 32), most of the tissues have
a preponderance of CD45RO+ memory T cells, whereas periph-
eral blood contains a comparable proportion of CD45RO+
and CD45RA+ subsets (Figure 2A). CD45RO+ memory T cells
predominate in mucosal sites including lung, jejunum, ileum,
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Figure 1. Lymphocyte Subset Frequency Is Intrinsic to the Tissue Site within and between Individuals
Lymphocytes were isolated from the tissues indicated in Table 1 and analyzed by flow cytometry.
(A) Representative flow cytometry plots showing CD3 and CD20 expression, indicating T and B cell subsets, respectively, gated on forward and side scatter
lymphocyte populations. Tissue designations from left to right: BLD, blood; LLN, lung lymph node; JEJ, jejunum; SPL, spleen; LUN, lung; ILE, ileum; ILN, inguinal
lymph node; MLN, mesenteric lymph node; COL, colon. Data derive from donor 3.
(B) Top: Graph shows relative T and B cell frequency in the nine tissue sites compiled from 14 donors (donors 1–4, 7–10, 12, 13, 20, 27, 33, 40) plotted as the ratio
of T cell:B cell frequency in each tissue site ± SEM. Bottom: CD4+ and CD8+ T cell subset composition in different human tissue sites calculated as the mean ratio
CD4+:CD8+ T cell frequency ± SEM within CD3+ cells from 17 individual donors (donors 1–4, 7–10, 12, 13, 16, 18, 26, 27, 33, 39, 40). Individualized data sets for
each donor are shown in Table S1.
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Human T Cells in Lymphoid and Mucosal Tissuesand colon (>90% of total T cells) and although their frequency in
lymphoid tissue was reduced compared to mucosal sites (60%–
70%), it still exceeded that of CD45RA-expressing subsets (Fig-
ure 2A). Similar results were observed in adult donors aged 30 or
older, with a representative older donor shown in Figure S1B. In
a representative younger donor, CD45RA+ cells were at a higher
frequency than CD45RO+ cells in lymphoid tissues, ranging from
40% to 70%,whereas the CD45RO+ subset still predominated in
mucosal sites representing 70%–95% of total T cells (Fig-
ure S1A). These results demonstrate that human memory
T cells predominate throughout the body and particularly in
mucosal sites of all individuals, although their frequency in
lymphoid tissue may vary with age.
We further investigated the age dependence of memory T cell
frequency in the body by compiling results from three donor age
groups: one representing teens and young adults (<25 years),
a second representing individuals in middle years (30–50 years),
and a third comprising those in the sixth decade of life (50–60
years) (Figure 2B; individual data sets shown in Table S1). In
mucosal sites and in spleen, both CD4+ and CD8+ T cells were
predominantly memory (60%–90%) throughout all stages of
life, with intestines containing a higher proportion of memory
T cells compared to lung and spleen (Figure 2B). In blood and
lymph nodes, the frequency of memory CD4+ T cells differed
significantly between the youngest and two older groups (p <
0.0005, Figure 2B), being present in low frequency (average30%) in younger donors and comprising >50%–70% in the two
older adult groups, ages 30–60 (Figure 2B, left). By contrast,
memory CD8+ T cells remained a minority population (<40%) in
blood and lymph nodes in all age groups with CD45RA+CD8+
T cells prevailing in these sites (Figure 2B). Our findings therefore
show that over decades of life, memory CD4+ T cells accumulate
in lymphoid tissue to proportions seen in mucosal sites, whereas
memory CD8+ T cells retain their biased predominance in
mucosal sites and do not accumulate over time in lymphoid
compartments.
Distinct Composition and Compartmentalization
of CD4+ and CD8+ Effector and Memory Subsets
In humans, heterogeneous expression of the lymph node
homing receptor CCR7 defines additional functional subsets of
CD45RA+ and CD45RO+ T cells. Naive T cells are primarily
CD45RA+CCR7+. There is also a subset of CD45RA+ T cells
that are CCR7 negative, which are designated terminally differ-
entiated effector T cells (designated Temra cells) (Sallusto
et al., 2004). CD45RO+ memory T cells are subdivided into two
subsets: CCR7+ ‘‘central memory’’ (Tcm) cells, which migrate
to lymphoid tissue, and CCR7 ‘‘effector memory’’ (Tem) cells,
which circulate to nonlymphoid sites (Masopust et al., 2001;
Sallusto et al., 1999, 2004). We used coordinate analysis of
CCR7 and CD45RA expression by CD4+ and CD8+ T cells in
each site to precisely define how naive, Temra, Tcm, and TemImmunity 38, 187–197, January 24, 2013 ª2013 Elsevier Inc. 189
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Figure 2. Memory T Cells Predominate throughout the Body and
Vary with Age in Lymphoid Compartments
Lymphocytes isolated from indicated donor tissues were analyzed for
CD45RO expression to delineate memory cells from CD45RA-expressing
subsets representing either naive or terminal effector cells.
(A) Representative flow cytometry analysis of CD45RA and CD45RO expres-
sion from CD4+ T cells (left) and CD8+ T cells (right) from donor 39, aged 32.
Tissue designations from left to right: BLD, blood; LLN, lung lymph node; JEJ,
jejunum; SPL, spleen; LUN, lung; ILE, ileum; ILN, inguinal lymph node; MLN,
mesenteric lymph node; COL, colon.
(B) Change in memory T cell frequency and distribution in different age groups.
Plots show the mean frequency (±SEM) of memory (CD45RO+) CD4+ (left) and
CD8+ (right) T cells in different tissues compiled from individuals of three age
groupings: young (<20 years; n = 5), middle (30–50 years, n = 7), and older
(50–60 years, n = 5). Differences in the overall proportion of memory CD4+
T cells is highly significant comparing the <20 to the 30–50 year group (p = 33
107) or comparing the <20 to the 51–60 year group (p = 0.0005), but not
significant comparing the 30–50 year to the 51–60 year group (p = 0.57). For
CD8+ T cells, differences in the proportion of memory T cells was significant
comparing the <20 year to the 30–50 year group (p = 0.003) or to the 51–60
year group (p = 0.04), but not significant between the 30–50 year and 51–60
year groups (p = 0.33). CD45RO frequency for each of the 17 donors analyzed
(donors 1–3, 7–10, 12, 13, 16, 18, 20, 27, 29, 33, 39, 40) is shown in Table S1.
See also Figure S1.
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Human T Cells in Lymphoid and Mucosal Tissuescell subsets are organized within an individual (Figure 3A) and
whether tissue-specific patterns are conserved between individ-
uals (compiled results from nine donors in Figure 3B, with indi-
vidual data sets shown in Table S2). Analysis of CD4+ T cells
subsets revealed that they comprise naive, Tcm, and Tem cell
populations with tissue-intrinsic distribution: blood and lymph
nodes contained naive, CD4+ Tcm, and Tem cells in similar
proportions; spleen and lung had mostly Tem cells followed by
Tcm cell subsets; and intestinal sites contained predominantly
Tem cells, with Tcm CD4+ cells also present in colon (Figure 3B,
left). The composition and distribution of CD8+ T cells, however,
differed in several ways from that of CD4+ T cells. First, CD8+
Tcm cells existed in very low frequencies throughout the body
(even in lymphoid tissue); second, the Temra cell subset was
found only among CD8+ T cells and only significantly in blood,190 Immunity 38, 187–197, January 24, 2013 ª2013 Elsevier Inc.spleen, and lung and not in other sites; third, naive phenotype
CD8+ T cells were present in higher frequencies in blood and
lymph nodes compared to their frequency among CD4+
T cells; and finally, CD8+ Tem cells completely predominated
in intestinal tissues (Figure 3B, right). A frequency composite of
the tissue-specific subset composition of CD4+ and CD8+
T cells (Figure 3B, bottom) reveals that CD4+ T cells were main-
tained as naive, Tcm, and Tem cell subsets, whereas CD8+
T cells persisted as naive, Temra, and Tem cell populations.
For both CD4+ and CD8+ T cells, the proportion and distribution
of these subsets in each tissue is likewise consistent between
diverse individuals (Figure 3B and Table S2). Our results there-
fore demonstrate that the differentiation and maintenance of
CD4+ and CD8+ T cells within an individual are intrinsic to the
tissue compartment and cell lineage.
CD69 Expression Distinguishes Tissue-Resident from
Circulating Memory and Effector Subsets
In all donors examined, memory (CD45RO+) CD4+ and CD8+
T cells in lymphoid and mucosal tissue sites exhibited constitu-
tive upregulation of the early TCR-coupled activation marker
CD69, with 60%–100% of memory T cells in tissues being
CD69+ (Figures 4A andS2 and Table S3). By contrast, themajority
of memory T cells in blood were CD69 negative, with CD69 ex-
pression found on only 1%–20% of circulating memory T cells in
16/19 donors analyzed (Table S3). CD45RA+ T cells in all sites
were also predominantly CD69 negative, including 100% of naive
T cells in blood and 70%–95%CD45RA+ T cells in tissues (Figures
4A and S2 and Table S3). CD69hi memory T cells in lymphoid
and mucosal sites were largely IL-7R+ (Figure 4B), indicative of
a resting memory T cell phenotype, as IL-7R is downregulated
on activated effector T cells (Dooms et al., 2007; Kaech et al.,
2003; Paiardini et al., 2005; Seddiki et al., 2006). Together, these
results show specific upregulation of CD69 on resting memory
T cells in lymphoid and mucosal tissues.
We combined multiparameter analysis of memory subset
markers (CD45RO and CCR7) with CD69 as a marker of tissue
residence to obtain a composite picture of circulating and
tissue-resident memory CD4+ and CD8+ T cell subsets
throughout the body (Figure 4C). Memory T cells in the whole
body comprise circulating central memory (Tcm; CCR7+CD69),
circulating effector memory (Tem; CCR7CD69), resident
central memory (rTcm; CCR7+CD69+), and resident effector
memory (rTem; CCR7CD69+) T cell subsets (Figure 4C). The
composition of resident and circulating memory subsets was
specific to each compartment within an individual and differed
in blood, spleen, LN, and mucosal sites. Blood contained circu-
lating Tem and Tcm cells equivalently represented among CD4+
cells and mostly Tem cells for CD8+ cells, whereas spleen was
enriched for Tem and rTem CD4+ and CD8+ cells. Lymph nodes
contained CD4+ rTcm and rTem cell subsets and CD8+ rTem
cells, with a small proportion of circulating CD4+ Tcm cells (Fig-
ure 4C). Mucosal sites likewise differed in subset composition:
lung contained a predominant rTem cell subset, a low-frequency
rTcm cell fraction, and minority populations of circulating Tcm
and Tem cell subsets (Figure 4C). By contrast, all intestinal sites
examined including jejunum, ileum, and colon contained only
CD4+ and CD8+ rTem cells (Figure 4C and data not shown).
These results indicate that circulating subsets are present in
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Figure 3. Distinct Tissue Distribution and
Subset Composition of Naive, Memory,
and Terminal Effector CD4+ and CD8+
T Cell Subsets
(A) Coordinate expression of CD45RA and CCR7
by CD4+ (left) and CD8+ (right) T cells in blood
and eight tissue sites delineates four subsets
corresponding to naive (CD45RA+CCR7+, top right
quadrant), terminal effector (Temra, CD45RA+
CCR7, top left quadrant), central memory (Tcm,
CD45RACCR7+, top right quadrant), and effector
memory (Tem, CD45RACCR7, top left quad-
rant) T cells. Results shown are from donor 41,
representative of nine donors.
(B) Frequency of CD4+ (left) and CD8+ (right) naive
(red), Temra (black), Tcm (yellow), and Tem (gray)
cell subsets in each tissue site, compiled from nine
donors (donors 3, 15, 39–45; individualized data
sets for each donor shown in Table S2). Small
individual graphs show frequency of each subset
in each site expressed as mean ± SEM, calculated
from dot plots as in (A). Bottom: Large composite
graphs show average frequency of each subset
(naive, Temra, Tcm, Tem) within CD4+ (left) or
CD8+ (right) T cells in each tissue site.
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Human T Cells in Lymphoid and Mucosal Tissueslow frequencies only in certain tissue sites such as spleen, LN,
and lungs and are completely absent from intestines, and that
resident memory T cells predominate in lymphoid and mucosal
sites and do not circulate in blood.
CD103 Expression Defines Mucosal Memory CD8+ T
Cells
CD103 expression is associated with intestinal immune cell
populations and tissue-infiltrating effector CD8+ T cells in mice
(Scho¨n et al., 1999; Sheridan and Lefranc¸ois, 2011). We found
that CD8+ rTem cells in mucosal sites were further distinguished
by expression of the integrin CD103 (Figure 5). Within an indi-
vidual, all memory CD8+ T cells in small intestine and colon
were CD103+, with significant fractions of CD103+ memory
CD8+ T cells in lung and intestinal-draining LN, whereas blood,
spleen, and peripheral LN memory CD8+ T cells were uniformly
CD103 (Figure 5A). A proportion of CD8+ Temra cells in intes-Immunity 38, 187–197tines showed upregulated CD103 expres-
sion, although not to the same extent
observed bymemory T cells in these sites
(Figure 5A). This compartmentalized
expression of CD103 on mucosal
memory CD8+ T cells was consistent
between all donors examined (Figure 5B
and Table S3). Together, these results
show that intestinal CD8+ rTem cells are
not equivalent to rTem cells in other tissue
sites and suggest tissue-specific influ-
ences on resident Tem cells.
Functional Profile of T Cells
Resident in Different Tissue Sites
A hallmark of memory T cells is their rapid
functional recall within hours of stimula-tion. We examined whether the functional capacity of memory
CD4+ or CD8+ T cells was differentially compartmentalized in
tissue sites. After short-term stimulation with PMA+ionomycin,
the two most abundant cytokines produced by human CD4+
and CD8+ T cells in all sites were IFN-g and IL-2 (Figure 6A), fol-
lowed by TNF-a with minimal IL-4 and IL-10 at rapid times (data
not shown). CD4+ T cells had comparable proportions of IL-2 and
IFN-g producers in the blood; however, in all tissues, the
predominant cytokine secreted byCD4+ T cells was IL-2 (Figures
6A and S3A). In contrast, CD8+ T cells showed a preponderance
of rapid IFN-g producers in the blood and all tissue sites, with
dual IFN-g/IL-2 producers found only in tissue sites, represent-
ing 30%–50% of the total IFN-g producers (Figure 6A). This
differential pattern of IL-2 and IFN-g secretion by CD4+ and
CD8+ T cells in tissue sites was conserved between donors (Fig-
ure S3A and Table S4). Memory CD4+ and CD8+ T cells in each
site were the main source of rapid IL-2 and IFN-g production,, January 24, 2013 ª2013 Elsevier Inc. 191
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Figure 4. CD69 Expression Distinguishes Tissue-Resident from Circulating Memory T Cell Subsets
(A) Mean frequency (±SEM) of CD69+ T cells gated on CD45RA+ (red bars) and CD45RO+ (blue bars) CD4+ (left) and CD8+ (right) T cells in blood and tissues
compiled from 19 donors (donors 1, 7–10, 12–15, 27, 29, 33, 39–45; individual frequencies from each tissue of each donor are shown in Table S3, top).
(B) IL-7 receptor (CD127) is expressed by themajority of CD69+ tissue-resident memory T cells in lymphoid andmucosal sites. Flow cytometry plots show CD127
expression as a function of CD69 expression gated onCD45RO+CD4+ (top) or CD8+ (bottom) T cells in blood and indicated tissue sites. Results are from donor 41
and representative of five donors.
(C) CCR7 and CD69 expression by CD45RO+CD4+ (top) and CD8+ (bottom) T cells delineates four subsets: circulating central memory (Tcm; CCR7+CD69),
circulating effector memory (Tem; CCR7CD69), resident Tcm (rTcm; CCR7+CD69+), and resident Tem (rTem; CCR7CD69+) cell subsets (see leftmost
quadrant diagram). Results are from donor 39 and representative of seven donors.
See also Figure S2 and Table S4.
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Human T Cells in Lymphoid and Mucosal Tissuesrespectively, with a small proportion of CD45RA+CD8+ T cells
producing IFN-g in spleen, lungs, and intestines (Figure S3B),
probably derived from Temra cells in these sites. Comparing
the absolute frequency of IL-2-, IFN-g-, and dual-producing
CD4+ and CD8+ T cells in the nine sites reveals that quiescent
CD4+ T cells, which did not secrete rapid cytokines, were the
most abundant population throughout the body, followed by
memory CD4+ T cells producing IL-2, dual IFN-g- and IL-2-
producing CD4+ T cells, and IFN-g-producing CD8+ T cells
(Figure 6B).192 Immunity 38, 187–197, January 24, 2013 ª2013 Elsevier Inc.We also assessed production of the proinflammatory cyto-
kine IL-17 known to be associated with T cells in mucosal
and inflammatory sites (Dubin and Kolls, 2008; Korn et al.,
2009; Marks and Craft, 2009), subsequent to short-term stimu-
lation of T cells in blood, lymphoid, and mucosal sites. We de-
tected IL-17 production only from PMA+ionomycin-stimulated
memory CD4+ T cells in mucosal sites (and not from CD8+
T cells, data not shown), with the highest proportion from colon
and ileum, lower frequencies in lung and mucosal-draining LN,
and negligible production from T cells in blood and spleen
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Figure 5. The Integrin CD103 Specifically Marks Mucosal CD8+ T Cells
(A) Expression of CD103 by CD45RO+ (blue histogram) and CD45RA+ (red-filled histogram) CD4+ (left) and CD8+ (right) T cells from blood and eight tissue sites.
Results shown are from donor 40 and are representative of 11 donors.
(B) CD103 expression on CD45RO+ and CD45RA+ CD4+ (left) and CD8+ (right) T cells shown as percent CD103+ for each subset from each tissue site compiled
from 11 donors (donors 1, 7–10, 12–15, 27, 29, 33; individual frequencies for each donor in each site are presented in Table S3, bottom).
See also Figure S3 and Table S4.
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analysis of T cell responses throughout the body show that
a limited population of resident T cells has the capacity for
immediate effector responses, with the majority of T cells in
the body being quiescent or IL-2-producing memory CD4+
T cells, and IL-17 production showing tissue-specific and
subset-specific compartmentalization.
DISCUSSION
We have taken a major step in elucidating fundamental aspects
of human adaptive immunity by studying T cells isolated from
human tissues obtained from organ donors. The resultant
phenotypic and functional analysis of CD4+ and CD8+ T cells
from blood, lymphoid, and mucosal sites of 24 individuals
reveals insights into how T cell subsets are distributed and func-tionally maintained throughout the body. Specifically, CD4+
T cells are the most abundant subset in tissue sites, with effector
memory CD4+ T cells prevalent in mucosal tissues and accumu-
lating as central memory subsets in lymphoid sites. CD8+ T cells
are distributed as predominant effector memory populations in
mucosal tissue and spleen and as terminal effector cells in circu-
lation and are maintained as naive cells in lymphoid tissue.
Importantly, all memory T cells in lymphoid and mucosal sites
constitutively express CD69, contrasting circulating memory
T cells and all naive subsets, and defining resident memory pop-
ulations, with CD103 expression specific to mucosal memory
CD8+ T cells. Functionally, the majority of tissue-resident
T cells were quiescent or IL-2-producing memory CD4+ T cells
with lower frequencies of effector CD8+ T cells, and IL-17
production was confined to mucosal tissue. Our results show
how human T cells are compartmentalized throughout theImmunity 38, 187–197, January 24, 2013 ª2013 Elsevier Inc. 193
AB C
Figure 6. Functional Profile of T Cells in
Lymphoid and Mucosal Tissues
T cells purified from indicated tissue sites were
stimulated for 4 hr with PMA+ionomycin and
cytokine production was assessed by intracellular
cytokine staining (ICS).
(A) IFN-g and IL-2 production by CD4+ and CD8+
T cells in different tissue sites, with gates drawn
based on unstimulated controls. Numbers in
quadrants indicates percent of CD4+ T cells (left)
or CD8+ T cells (right) producing IFN-g, IL-2, or
both cytokines. Results are from donor 29,
representative of four donors (18, 26, 27, and 29)
from which coordinate analysis of IFN-g and IL-2
production was accomplished.
(B) Individual pie chart diagrams showing the
frequency of CD4+ and CD8+ T cells with rapid
cytokine-producing capacity in each tissue site
from one donor, representative of four donors,
showing a high proportion of quiescent CD4+
T cells in each site and a minority population of
effector memory CD4+ or CD8+ T cells.
(C) IL-17 production is confined to memory CD4+
T cells in mucosal sites. Top: Representative ICS
analysis of IL-17 production from spleen, mucosal
draining LN, lung, and intestinal sites from donor 9.
Bottom: Mean IL-17 production (±SEM) from
blood and tissue of five donors where we analyzed
IL-17 expression (donors 9, 10, 18, 26, 27).
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responses and defining disease-specific immune pathologies.
Previous studies on T cells isolated from human tissues have
been limited to individual tissues surgically excised because of
disease or chronic inflammation, including tonsils obtained
from tonsillectomies (Bentebibel et al., 2011), lungs frompatients
with lung cancer (Purwar et al., 2011), and intestines from IBD
patients (Hovhannisyan et al., 2011). The steady state of T cells
in healthy tissues within a single individual has not previously
been investigated or defined. Here, brain-dead organ donors
who died of traumatic, nonimmunological causes were used as
source of tissues for immunological analysis, which were ob-
tained coincident with organ acquisition for clinical transplanta-
tion. The immediate isolation of cells with high viability from
these tissues enabled an in-depth ex vivo analysis of human T
lymphocytes from multiple anatomic compartments in ways194 Immunity 38, 187–197, January 24, 2013 ª2013 Elsevier Inc.previously possible to achieve only in
mice. However, in mice, tissue immune
responses have been examined after
infection of inbred mouse strains with
a single pathogen, and it is not known
whether infection with many diverse
pathogens and maintenance of the
immune system for decades of life will
result in large variations in T cell subset
composition throughout and within tissue
sites. From our analysis of tissues from 24
different donors, we found notable
consistencies in the compartmentaliza-
tion of T cell subsets between donors
despite different causes of death, diverselifestyles, and the known heterogeneity of the human population.
These findings indicate that the organization, differentiation,
and maintenance of human T cells is strikingly tissue intrinsic
and that tissue from organ donors as obtained here is a valuable
source for analyzing steady-state immune responses.
We found notable disparities in human CD4+ and CD8+ T cell
subset compartmentalization throughout the body. CD4+
T cells are maintained as naive, Tcm, and Tem cell subsets
with no appreciable Temra cell subsets, whereas CD8+ T cells
persist as naive, Temra, and Tem cell populations, with CD8+
Tcm cells present in low frequencies in lymphoid tissue and
negligible frequencies in other sites. The low proportion of
CD8+ Tcm cells compared to CD4+ Tcm cells was not predicted
from analysis of peripheral blood (Gattinoni et al., 2011; Sallusto
et al., 1999) and is most striking when comparing whole
body subset delineation as accomplished here. Interestingly,
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blood, spleen, and lung, where circulating populations are
found. These results suggest that CD8+ T cells may be actively
responding to antigenic stimulation through interaction with
MHC class I-expressing cells in tissues and resulting in effector
differentiation and migration to the periphery. An in-depth
analysis of gene expression in CD4+ and CD8+ T cell subsets
in the tissues will be essential to dissect their lineage relationship
and origin.
In addition to differences in composition, CD4+ and CD8+
T cell subsets also exhibit distinct patterns of maintenance in
lymphoid tissues. In younger individuals, CD4+ T cells were
comparably apportioned into naive and memory subsets in
lymphoid tissues, but in donors aged 30 or older, memory
CD4+ T cells represented the majority population in lymphoid
tissue. By contrast, naive CD8+ T cells were the majority popula-
tion in blood and lymph nodes throughout six decades of life.
Maintenance of a high proportion of naive CD8+ T cells in
lymphoid tissue could arise from a lack of significant recycling
of memory CD8+ T cells back to lymphoid compartments
because of the paucity of Tcm cells among CD8+ T cells. Alter-
nately, differences in homeostatic turnover between CD4+ and
CD8+ T cells could contribute to differences in memory accumu-
lation, as shown by the fact that phenotypic conversion of mouse
and human naive T cells to memory cells can occur because of
homeostatic expansion independent of effector differentiation
(Onoe et al., 2010; Purton et al., 2007; Surh and Sprent, 2008;
Tan et al., 2002). Thus, the dynamic accumulation of IL-2-
producing memory CD4+ T cells in LN may arise by homeostatic
turnover, whereas human CD8+ T cells may be less susceptible
to homeostasis-driven alterations compared to CD4+ counter-
parts, resulting in more stable maintenance of naive CD8+
T cells in lymphoid tissue. Conversely, the compartmentalization
of effector memory CD8+ T cells in mucosal sites could indicate
antigen-driven differentiation and stable retention of differenti-
ated memory T cells in mucosal compartments. An evaluation
of TCR clonality and repertoire in future studies will provide
insights into how CD4+ and CD8+ T cells are maintained and
circulate throughout the body.
In all donors, we found that the majority (>80%) of memory
T cells in lymphoid and mucosal tissue had constitutive CD69
expression, whereas circulating memory T cells in blood were
predominantly CD69 negative. CD69 is a well-known early
marker of TCR signaling in humans and mice (Krishnan et al.,
2001; Ziegler et al., 1994) and can also be upregulated by mouse
CD8+ T cells in response to type I IFN (Sun et al., 1998). CD69+
memory T cells have been identified in the skin, lungs, and intes-
tines of humans and mice (Clark et al., 2012; Jiang et al., 2012;
Masopust et al., 2006, 2010; Teijaro et al., 2011), althoughmouse
memory T cells in spleen and LN are known to be CD69lo (Casey
et al., 2012; Teijaro et al., 2011). However, we found that human
memory T cells in LN and spleen were CD69+, indicating a key
difference in either the maintenance or signaling state of human
lymphoid compared to mouse lymphoid memory T cells. Tissue-
resident CD69+ human memory T cells appeared quiescent as
they maintained expression of IL-7R and were CD25 negative.
Moreover, CD69 upregulation identified here was not due to
tissue digestion or incubation because T cells isolated from LN
and mucosal sites by mechanical, nonenzymatic disruptionwere likewise CD69+ (data not shown). We propose that CD69
upregulation by tissue memory T cells may derive from low-level
TCR engagement, responses to cytokines, and/or tonic
signaling by interaction with tissue-resident DCs or tissue
accessory cells. This heightened activation state of tissue
memory T cells may facilitate responses to low antigen doses
or to costimulation-based second signals, increasing protective
responses to site-specific pathogens.
Molecules expressed by tissue-resident memory T cells may
also play roles in their retention. For example, CD69 upregulation
by activated mouse T cells was shown to trigger retention in LN
(Shiow et al., 2006). In addition, CD103, shown here to be ex-
pressed specifically by human mucosal memory CD8+ T cells,
is also known to play a role in retention in mouse intestines
because of its interaction with E-cadherin on epithelial cells
(Scho¨n et al., 1999; Sheridan and Lefranc¸ois, 2011). In addition,
T cell specificity may also mediate retention of certain T cell
clonal populations. IL-17 production is has been associated
with responses to intestinal microbiota in mice (Ivanov et al.,
2008, 2009), and our finding that IL-17 production is confined
to human memory CD4+ T cells in mucosal sites suggests active
retention of this functional subset through mucosal-specific
factors. Moreover, the presence of IL-17+ memory CD4+
T cells in mucosal-draining lymphoid tissues suggests that
lymphoid tissue may be active sites of local priming for IL-17+
memory CD4+ T cells.
Our findings indicate that the subset composition and pheno-
type of peripheral blood T cells does not reflect that of spleen,
lymph nodes, or mucosal tissues, suggesting that blood is
a distinct compartment. Our results also suggest potential traf-
ficking patterns for migration of circulating and tissue-resident
naive, effector, and memory T cell subsets in blood, lymphoid,
and mucosal tissues. Blood-borne T cell subsets (naive, Temra,
Tcm, Tem) can enter certain tissue sites such as spleen, lung,
and LN in low frequency but are never found in intestinal sites.
Moreover, the major subsets in all tissue sites are resident
memory, with rTem cell populations predominating in lung, intes-
tines, and spleen and CD4+ rTcm (CD4+) cells predominating in
peripheral and tissue-draining LN along with CD4+ and CD8+
rTem cells. The origin of tissue-resident cells is not clear,
although in mucosal sites, tissue-specific factors may act on
its T cell inhabitants to maintain their residence and prevent
egress, through the expression of molecules such as CD103.
Molecular profiling of resident versus circulating subsets in
future studies will provide keys to their lineage relationships
and tissue-specific profiles.
Basic knowledge of the properties of human tissue T cells
throughout the body, for which the findings in this paper repre-
sent an important step, can contribute to a better understanding
of a wide range of human diseases. Already, the findings pre-
sented here establish a fundamental baseline for steady-state
human T cell immunity that can be applied to define more
precisely the immune dysfunctions associated with site-specific
and systemic autoimmune and inflammatory diseases. Under-
standing the origin and identity of tissue-resident T cell popula-
tions can also lead to therapies that target memory T cells to
the specific sites of pathogen entry and persistence for protec-
tion. In conclusion, our approach to study human immune cells
in tissue sites will open the door to fundamental studies onImmunity 38, 187–197, January 24, 2013 ª2013 Elsevier Inc. 195
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to translate and optimize immunotherapies.
EXPERIMENTAL PROCEDURES
Acquisition of Human Tissues
Tissues were acquired from deceased organ donors in the OR at the time of
organ acquisition for clinical transplantation through an approved research
protocol and MTA with the NYODN. At the time of death, all donors were
free of chronic disease and cancer, were HIV negative, andwere aged 60 years
or younger. Because tissues were obtained from deceased individuals, the
study does not qualify as ‘‘human subjects’’ research, as confirmed by the
Columbia University IRB. Consent for use of donor tissues for research was
obtained by NYODN transplant coordinators.
Lymphocyte Isolation from Human Lymphoid and Nonlymphoid
Tissues
Tissue samples were maintained in cold saline and brought to the lab within
4–6 hr of organ procurement. In order to achieve high-quality, viable lympho-
cytes, we developed a rapid cell isolation protocol combining enzymatic
digestion and mechanical dissociation. We avoided DTT and EDTA steps
and longer incubation periods for nonlymphoid tissue to minimize isolation
time without impacting sample quality. Spleen (1–2 cm2), inguinal LN (2–3 no-
des), mesenteric LN (5–10 nodes), and bronchial LN (2–5 nodes) were chopped
into small pieces and placed into 50ml conical tubes and filled up to 50ml with
enzymatic digestion solution (RPMI containing 10%FBS, L-glutamate, sodium
pyruvate, nonessential amino acids, penicillin-streptomycin, collagenase D
[1 mg/ml], trypsin inhibitor [1 mg/ml], and DNase I [50–100 mg/ml]), and incu-
bated at 37C for 2 hr. Tissue digests were then mechanically disrupted with
the gentleMACS tissue dissociator (Milteyni Biotech), residual tissue frag-
ments were removed through a stainless steel tissue sieve (10 to 150 mesh
size), and the resultant cells were pelleted by centrifugation and resuspended
into 25 ml RPMI. For RBC removal, 1 ml of HetaSep (StemCell Technologies)
was added to 5ml of cell suspension and centrifuged at 503 g for 5 min at RT.
The resulting supernatant containing lymphocytes was carefully removed and
washed with PBS, with residual RBCs lysed with AKC lysis buffer. In order to
remove debris, fat, and dead cells, pellets were resuspended into 30% percoll
(GE Healthcare Life Sciences) and centrifuged at 50 3 g for 10 min at RT. The
top layer and pellet were discarded and cells were washed twice to remove
percoll.
Intestines and lungs were processed as above with the following modifica-
tions. Intestinal samples were dissected into three parts: jejunum, terminal
ileum, and ascending colon after isolation of mesenteric LN. Tissues were
cleaned of fat, Peyer’s patches were removed, and the subsequent intestinal
tissue segments were washed with sterile PBS. We injected 10–20 ml enzy-
matic digestion solution submucosally into intestinal segments and directly
into lung pieces, prior to chopping into small pieces and placement into
50 ml enzymatic digestions solution. An additional DNase step (50 mg/ml of
DNase for 15 min incubation at 37C) was inserted after mechanical disruption
for lungs and intestines. For PBMC isolation, samples were processed for RBC
removal steps as described above. The resultant lymphocyte-enriched cells
from all samples were resuspended into complete RPMI media containing
antibiotics resulting in >95% viability.
Flow Cytometry Analysis
We used 8–12 color flow cytometry analysis for phenotypic analysis of human
immune cells from tissue sites. The following fluorochrome-conjugated anti-
bodies were used: anti-human CD3 (eFluor Nanocrystal 650, OKT3, eBio-
science), CD4 (Qdot705, S3.5, Invitrogen), CD8 (Allophycocyanin/Cy7, SK1,
Biolegend), CD45RA (Qdot605, MEM-56, Invitrogen), CD45RO (PerCP-eFluor
710, UCHL1, eBioscience), CD28 (Phycoerythrin/Cy7, CD28.2, Biolegend),
CCR7 (Alexa Fluor 488, TG8/CCR7, Biolegend), CD69 (Brilliant Violet 488,
FN50, Biolegend), CD20 (Phycoerythrin, 2H7, Biolegend), CD103 (Alexa Fluor
488 or Phycoerythrin, Ber-ACT8, Biolegend), CD127 (Allophycocyanin,
A019D5, Biolegend), and CD25 (brilliant violet, BC96, Biolegend). SYTOX
blue (Invitrogen) was used for live-dead cell analysis. Cells were stained with
fluorochrome-conjugated antibodies (8–12 color panel) and were acquired196 Immunity 38, 187–197, January 24, 2013 ª2013 Elsevier Inc.on a 6-laser LSR II analytical flow cytometer (BD Biosciences, San Jose, CA)
via FACSDiva software in the Columbia Center for Translational Immunology
(CCTI) flow cytometry core. Control samples included unstained and single
fluorochrome-stained cells for accurate compensation and data analysis.
Results were analyzed with FlowJo software.
Functional Analysis
For T cell stimulation, 1–23 106 total cells in 200 ml of complete RPMI medium
containing PMA (50 ng/ml) plus ionomycin (1 mg/ml) were plated in 96-well
round-bottom plates and incubated at 37C for 4–5 hr in the presence of BD
Golgi plug (Brefeldin A). The cells were washed with PBS and fixed at RT
with 1.6% PFA and stored at 4C. The cells were stained for surface pheno-
typic marker followed by permeabilization (saponin) and intracellular cytokine
staining. The following cytokine antibodies were used: IL-2 (Brilliant Violet 421,
17H12, Biolegend), IL-17A (Alexa Fluor 488, BL168, Biolegend), TNF-a
(Allophycocyanin, MA611, Biolegend), and IFN-g (Phycoerythrin, 4S.B3, BD
PharMingen).
Statistical Analysis
The statistical and graphical analyses were done with GraphPad prism soft-
ware and Microsoft Excel. One-tailed t tests were used to assess significance.
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